Replies to post #106242 on Biotech Values

[DewDiligence]

PFE’s Embeda expected to be back on the US market in 2Q14, following FDA approval today of manufacturing change:

http://finance.yahoo.com/news/pfizer-receives-fda-approval-prior-221400030.html

PFE acquired Embeda as part of the King Pharma deal in 2010 (#msg-55459946).